NO20031939L - Acyl- og sulfonylderivater av 6,9-disubstituerte 2-(trans-1,4-diaminocykloheksyl)-puriner og deres anvendelse som antiproliferative midler - Google Patents
Acyl- og sulfonylderivater av 6,9-disubstituerte 2-(trans-1,4-diaminocykloheksyl)-puriner og deres anvendelse som antiproliferative midlerInfo
- Publication number
- NO20031939L NO20031939L NO20031939A NO20031939A NO20031939L NO 20031939 L NO20031939 L NO 20031939L NO 20031939 A NO20031939 A NO 20031939A NO 20031939 A NO20031939 A NO 20031939A NO 20031939 L NO20031939 L NO 20031939L
- Authority
- NO
- Norway
- Prior art keywords
- diaminocyclohexyl
- purines
- disubstituted
- acyl
- trans
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 title abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 title abstract 2
- 150000003212 purines Chemical class 0.000 title 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24456700P | 2000-10-31 | 2000-10-31 | |
| GBGB0117075.2A GB0117075D0 (en) | 2000-10-31 | 2001-07-13 | Acyl and sulfonyl derivatives of 6, 9-distributed 2-(trans-1, 4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
| PCT/US2001/044835 WO2002042303A2 (en) | 2000-10-31 | 2001-10-31 | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031939D0 NO20031939D0 (no) | 2003-04-29 |
| NO20031939L true NO20031939L (no) | 2003-06-19 |
Family
ID=26246308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031939A NO20031939L (no) | 2000-10-31 | 2003-04-29 | Acyl- og sulfonylderivater av 6,9-disubstituerte 2-(trans-1,4-diaminocykloheksyl)-puriner og deres anvendelse som antiproliferative midler |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1377579B1 (de) |
| JP (1) | JP4348081B2 (de) |
| AT (1) | ATE426603T1 (de) |
| AU (2) | AU3938802A (de) |
| BR (1) | BR0115080A (de) |
| CA (1) | CA2427338C (de) |
| DE (1) | DE60138140D1 (de) |
| DK (1) | DK1377579T3 (de) |
| ES (1) | ES2324763T3 (de) |
| IL (1) | IL155590A0 (de) |
| MX (1) | MXPA03003774A (de) |
| NO (1) | NO20031939L (de) |
| NZ (1) | NZ525264A (de) |
| WO (1) | WO2002042303A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7563810B2 (en) * | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
| FR2851248B1 (fr) * | 2003-02-18 | 2005-04-08 | Aventis Pharma Sa | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| BRPI0410654A (pt) * | 2003-06-12 | 2006-06-20 | Novo Nordisk As | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto |
| MX2010010975A (es) * | 2008-04-07 | 2010-11-01 | Amgen Inc | Amino piridinas/pirimidinas gem-disustituidas y espirociclicas como inhibidores de ciclo celular. |
| US9180127B2 (en) | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
| CA2856291C (en) | 2011-11-17 | 2020-08-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
| US10047070B2 (en) | 2013-10-18 | 2018-08-14 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
| EP3236959B1 (de) | 2014-12-23 | 2025-09-24 | Dana-Farber Cancer Institute, Inc. | Hemmer der cyclinabhängigen kinase 7 (cdk7) |
| AU2016243529B2 (en) * | 2015-03-27 | 2021-03-25 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| EP4019515A1 (de) | 2015-09-09 | 2022-06-29 | Dana-Farber Cancer Institute, Inc. | Hemmer von cyclinabhängigen kinasen |
| JP7590185B2 (ja) | 2018-06-25 | 2024-11-26 | ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド | Ｔａｉｒｅファミリーキナーゼインヒビターおよびそれらの使用 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| MX2022001940A (es) | 2019-08-14 | 2022-05-10 | Incyte Corp | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2. |
| CN119930610A (zh) * | 2019-10-11 | 2025-05-06 | 因赛特公司 | 作为cdk2抑制剂的双环胺 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| AU2023393410A1 (en) | 2022-12-16 | 2025-07-31 | Astrazeneca Ab | 2,6,9-trisubstituted purines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479487B1 (en) * | 1998-02-26 | 2002-11-12 | Aventis Pharmaceuticals Inc. | 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines |
| WO1999043676A2 (en) * | 1998-02-26 | 1999-09-02 | Aventis Pharmaceuticals Inc. | 6,9-disubstituted 2-[trans-(4- aminocyclohexyl) amino]purines |
| FR2793794B1 (fr) * | 1999-05-21 | 2001-07-27 | Hoechst Marion Roussel Inc | Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| JP2004501062A (ja) * | 1999-12-17 | 2004-01-15 | アライアッド・ファーマシューティカルズ・インコーポレーテッド | 新規プリン類 |
| US20030187261A1 (en) * | 2000-01-07 | 2003-10-02 | Libor Havlicek | Purine derivatives, process for their preparation and use thereof |
-
2001
- 2001-10-31 AT AT01987144T patent/ATE426603T1/de active
- 2001-10-31 MX MXPA03003774A patent/MXPA03003774A/es active IP Right Grant
- 2001-10-31 AU AU3938802A patent/AU3938802A/xx active Pending
- 2001-10-31 DE DE60138140T patent/DE60138140D1/de not_active Expired - Lifetime
- 2001-10-31 JP JP2002544437A patent/JP4348081B2/ja not_active Expired - Lifetime
- 2001-10-31 EP EP01987144A patent/EP1377579B1/de not_active Expired - Lifetime
- 2001-10-31 DK DK01987144T patent/DK1377579T3/da active
- 2001-10-31 ES ES01987144T patent/ES2324763T3/es not_active Expired - Lifetime
- 2001-10-31 NZ NZ525264A patent/NZ525264A/en not_active IP Right Cessation
- 2001-10-31 AU AU2002239388A patent/AU2002239388B2/en not_active Expired
- 2001-10-31 CA CA002427338A patent/CA2427338C/en not_active Expired - Lifetime
- 2001-10-31 WO PCT/US2001/044835 patent/WO2002042303A2/en not_active Ceased
- 2001-10-31 BR BR0115080-4A patent/BR0115080A/pt not_active Application Discontinuation
- 2001-10-31 IL IL15559001A patent/IL155590A0/xx unknown
-
2003
- 2003-04-29 NO NO20031939A patent/NO20031939L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1377579A2 (de) | 2004-01-07 |
| JP4348081B2 (ja) | 2009-10-21 |
| WO2002042303A2 (en) | 2002-05-30 |
| CA2427338C (en) | 2008-06-10 |
| AU3938802A (en) | 2002-06-03 |
| DE60138140D1 (de) | 2009-05-07 |
| NZ525264A (en) | 2005-12-23 |
| JP2004517075A (ja) | 2004-06-10 |
| ES2324763T3 (es) | 2009-08-14 |
| ATE426603T1 (de) | 2009-04-15 |
| MXPA03003774A (es) | 2003-07-28 |
| DK1377579T3 (da) | 2009-08-31 |
| NO20031939D0 (no) | 2003-04-29 |
| EP1377579B1 (de) | 2009-03-25 |
| IL155590A0 (en) | 2003-11-23 |
| WO2002042303A3 (en) | 2003-10-30 |
| CA2427338A1 (en) | 2002-05-30 |
| AU2002239388B2 (en) | 2006-05-25 |
| BR0115080A (pt) | 2003-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20031939L (no) | Acyl- og sulfonylderivater av 6,9-disubstituerte 2-(trans-1,4-diaminocykloheksyl)-puriner og deres anvendelse som antiproliferative midler | |
| DK0988292T3 (da) | Piperazinderivater og deres anvendelse som antiinflammationsmidler | |
| IT1309590B1 (it) | Derivati di 1-alcossi-polialchil-piperidine e loro impiego comeregolatori della polimerizzazione. | |
| ITRM20010356A0 (it) | "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina. | |
| NO20005265L (no) | Substituerte benzamider, deres fremstilling og anvendelse som inhibitorer av cystin-proteaser | |
| DE60219292D1 (de) | Pyrazolderivate zur behandlung von hiv | |
| NO20023613L (no) | Nikotinamid benzokondenserte heterocyclylderivater nyttige som selektive inhibitorer av PDE4 | |
| NO954427D0 (no) | Hiv-proteaseinhibitorer som er anvendbare for behandling av AIDS | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| DK1425014T3 (da) | Diarylcycloalkylderivater, fremgangsmåde til deres fremstilling og deres anvendelse som PPAR-aktivatorer | |
| NO20030374D0 (no) | Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter | |
| ATE332903T1 (de) | Kondensierte pyridoindolderivate | |
| DK0625987T3 (da) | Aminoacetylmercaptoacetylamid-derivater, der kan anvendes som inhibitorer af enkephalinase og ACE | |
| DK1073416T3 (da) | Anvendelse af NO som anti-inflammatorisk middel | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| ATE302776T1 (de) | Kondensierte pyridoindolderivate | |
| BR0308170A (pt) | Composição para limpeza lìquida aquosa, método para limpeza de um substrato, e, uso de um polioxometalato | |
| ATE259813T1 (de) | Triazolopyrimidinderivate | |
| DK1214302T3 (da) | Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere | |
| NO20030998L (no) | Arylpiperazinderivater og deres anvendelse som psykotropiske midler | |
| IS7334A (is) | Bensóþíasól- og bensoxasól-4,7-díonafleiður og notkun þeirra sem cdc25 fosfatasatálma | |
| IT1289154B1 (it) | Derivati di isoflavone loro preparazione e loro impiego terapeutico | |
| NO20003199D0 (no) | Benzo(C)kinolizinderivater og deres anvendelse som 5- <alfa>reduktaseinhibitorer | |
| CY1109900T1 (el) | Ακυλικα και σουλφονυλικα παραγωγα των 6,9-διϋποκατεστημενων 2-(τρανs-1,4-διαμινοκυκλοεξυλο)-πουρινων και η χρηση τους ως αντιπολλαπλασιαστικοι παραγοντες | |
| DE60118804D1 (de) | Stabile wässrige dispersionen von 1,2-benzoisothiazolin-3-on (bit) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |